Tocqueville Asset Management L.P. acquired a new position in shares of Cigna Group (NYSE:CI - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 4,741 shares of the health services provider's stock, valued at approximately $1,307,000.
Several other institutional investors have also recently made changes to their positions in the company. Wilkerson Advisory Group LLC acquired a new stake in Cigna Group during the fourth quarter valued at $25,000. Cedar Mountain Advisors LLC increased its holdings in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after buying an additional 68 shares in the last quarter. Kemnay Advisory Services Inc. acquired a new position in shares of Cigna Group in the fourth quarter worth about $29,000. Prosperity Bancshares Inc acquired a new position in shares of Cigna Group in the fourth quarter worth about $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new stake in shares of Cigna Group during the 2nd quarter worth about $34,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
CI has been the subject of several recent analyst reports. Wolfe Research restated an "outperform" rating and issued a $315.00 price target on shares of Cigna Group in a research note on Tuesday, June 16th. Wall Street Zen downgraded Cigna Group from a "buy" rating to a "hold" rating in a research report on Saturday, August 1st. The Goldman Sachs Group raised their price objective on Cigna Group from $335.00 to $340.00 and gave the company a "buy" rating in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft cut Cigna Group from a "buy" rating to a "hold" rating and cut their price objective for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Finally, Royal Bank Of Canada upped their target price on Cigna Group from $333.00 to $337.00 and gave the stock an "outperform" rating in a research note on Friday, May 1st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $339.45.
Read Our Latest Report on CI
Cigna Group Stock Down 1.1%
CI stock opened at $274.50 on Friday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a 50-day simple moving average of $284.63 and a 200-day simple moving average of $281.41. The stock has a market capitalization of $72.53 billion, a P/E ratio of 11.36, a P/E/G ratio of 0.95 and a beta of 0.29.
Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period last year, the company posted $7.20 EPS. Cigna Group's quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group's dividend payout ratio (DPR) is 25.82%.
Insider Activity at Cigna Group
In other news, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 23,012 shares of company stock worth $6,386,550. Company insiders own 0.60% of the company's stock.
Cigna Group Company Profile
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
